Apellis Pharmaceuticals, Inc. Exchange Agreements

4 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Exchange Agreement between Apellis Pharmaceuticals, Inc. and Investor for 3.500% Convertible Senior Notes due 2026
Exchange Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2022
Exchange Agreement between Apellis Pharmaceuticals, Inc. and Investor for 3.500% Convertible Senior Notes due 2026
Exchange Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2022
Exchange Agreement between Apellis Pharmaceuticals, Inc. and Investor for 3.500% Convertible Senior Notes due 2026
Exchange Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2021
Exchange Agreement between Apellis Pharmaceuticals, Inc. and Investor for 3.500% Convertible Senior Notes due 2026
Exchange Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2021